Cisplatin Therapy Does Not Worsen Renal Function in Severe Antenatal Bartter Syndrome

A 30-year-old man with severe antenatal Bartter syndrome, diagnosed and treated in infancy, developed testicular carcinoma. Despite the known renal complications of cisplatin, this drug was used for his chemotherapy because of its superior antineoplastic effect. Nonsteroidal anti-inflammatory drug administration was continued during cisplatin therapy. Despite an increase in his oral potassium requirement, renal function was maintained following completion of chemotherapy. In spite of its significant associated nephrotoxicity, cisplatin can be used in patients with severe antenatal Bartter syndrome if required for therapy of malignancy.Case Rep Nephrol Dial 2017;7:49 –54
Source: Case Reports in Nephrology and Dialysis - Category: Urology & Nephrology Source Type: research